A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus

Anouar Fanidi, Caroline Relton, Per Magne Ueland, Øivind Midttun, Stein Emil Vollset, Ruth C. Travis, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, H. Bas Bueno-De-Mesquita, Martine Ros, Heiner Boeing, Rosario Tumino, Salvatore Panico, Domenico Palli, Sabina Sieri, Paolo Vineis, María José Sánchez, José María Huerta, Aurelio Barricarte GurreaLeila Luján-Barroso, J. Ramón Quirós, Anne Tjønneland, Jytte Halkjær, Marie Christine Boutron-Ruault, Françoise Clavel-Chapelon, Claire Cadeau, Elisabete Weiderpass, Mikael Johansson, Elio Riboli, Paul Brennan, Mattias Johansson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Experimental and epidemiological data suggest that factors of one-carbon metabolism are important in the pathogenesis of several cancers, but prospective data on head and neck cancer (HNC) and esophagus cancer are limited. The European Prospective Investigation into Cancer and Nutrition (EPIC) study recruited 385,747 participants from 10 countries who donated a blood sample. The current study included 516 cancer cases of the head and neck and esophagus and 516 individually matched controls. Plasma levels of vitamins B2, B6, B9 (folate), B12, and methionine and homocysteine were measured in pre-diagnostic plasma samples and analyzed in relation to HNC and esophagus cancer risk, as well as post-diagnosis all-cause mortality. After controlling for risk factors, study participants with higher levels of homocysteine had elevated risk of HNC, the odds ratio (OR) in conditional analysis when comparing the top and bottom quartiles of homocysteine [ORQ4 vs. Q1] being 2.13 (95% confidence interval [95% CI] 1.13-4.00, p for trend 0.009). A slight decrease in HNC risk was also seen among subjects with higher levels of folate (ORQ4 vs. Q1 0.63, 95% CI 0.35-1.16, p for trend 0.02). Subgroup analyses by anatomical sub-site indicated particularly strong associations with circulating homocysteine for oral cavity and gum cancer (p for trend 8 × 10-4), as well as for oropharynx cancer (p for trend 0.008). Plasma concentrations of the other investigated biomarkers did not display any clear association with risk or survival. In conclusion, study participants with elevated circulating levels of homocysteine had increased risk of developing squamous cell carcinoma of the head and neck.

Original languageEnglish
Pages (from-to)915-927
Number of pages13
JournalInternational Journal of Cancer
Volume136
Issue number4
DOIs
Publication statusPublished - Feb 15 2015

Fingerprint

Homocysteine
Esophageal Neoplasms
Head and Neck Neoplasms
Carbon
Biomarkers
Prospective Studies
Folic Acid
Confidence Intervals
Oropharyngeal Neoplasms
Neoplasms
Vitamin B 6
Riboflavin
Gingiva
Methionine
Esophagus
Mouth
Odds Ratio
Mortality

Keywords

  • EPIC
  • Head and neck cancer
  • One-carbon metabolism

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fanidi, A., Relton, C., Ueland, P. M., Midttun, Ø., Vollset, S. E., Travis, R. C., ... Johansson, M. (2015). A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus. International Journal of Cancer, 136(4), 915-927. https://doi.org/10.1002/ijc.29051

A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus. / Fanidi, Anouar; Relton, Caroline; Ueland, Per Magne; Midttun, Øivind; Vollset, Stein Emil; Travis, Ruth C.; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Bueno-De-Mesquita, H. Bas; Ros, Martine; Boeing, Heiner; Tumino, Rosario; Panico, Salvatore; Palli, Domenico; Sieri, Sabina; Vineis, Paolo; Sánchez, María José; Huerta, José María; Gurrea, Aurelio Barricarte; Luján-Barroso, Leila; Quirós, J. Ramón; Tjønneland, Anne; Halkjær, Jytte; Boutron-Ruault, Marie Christine; Clavel-Chapelon, Françoise; Cadeau, Claire; Weiderpass, Elisabete; Johansson, Mikael; Riboli, Elio; Brennan, Paul; Johansson, Mattias.

In: International Journal of Cancer, Vol. 136, No. 4, 15.02.2015, p. 915-927.

Research output: Contribution to journalArticle

Fanidi, A, Relton, C, Ueland, PM, Midttun, Ø, Vollset, SE, Travis, RC, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Bueno-De-Mesquita, HB, Ros, M, Boeing, H, Tumino, R, Panico, S, Palli, D, Sieri, S, Vineis, P, Sánchez, MJ, Huerta, JM, Gurrea, AB, Luján-Barroso, L, Quirós, JR, Tjønneland, A, Halkjær, J, Boutron-Ruault, MC, Clavel-Chapelon, F, Cadeau, C, Weiderpass, E, Johansson, M, Riboli, E, Brennan, P & Johansson, M 2015, 'A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus', International Journal of Cancer, vol. 136, no. 4, pp. 915-927. https://doi.org/10.1002/ijc.29051
Fanidi, Anouar ; Relton, Caroline ; Ueland, Per Magne ; Midttun, Øivind ; Vollset, Stein Emil ; Travis, Ruth C. ; Trichopoulou, Antonia ; Lagiou, Pagona ; Trichopoulos, Dimitrios ; Bueno-De-Mesquita, H. Bas ; Ros, Martine ; Boeing, Heiner ; Tumino, Rosario ; Panico, Salvatore ; Palli, Domenico ; Sieri, Sabina ; Vineis, Paolo ; Sánchez, María José ; Huerta, José María ; Gurrea, Aurelio Barricarte ; Luján-Barroso, Leila ; Quirós, J. Ramón ; Tjønneland, Anne ; Halkjær, Jytte ; Boutron-Ruault, Marie Christine ; Clavel-Chapelon, Françoise ; Cadeau, Claire ; Weiderpass, Elisabete ; Johansson, Mikael ; Riboli, Elio ; Brennan, Paul ; Johansson, Mattias. / A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus. In: International Journal of Cancer. 2015 ; Vol. 136, No. 4. pp. 915-927.
@article{843563055cba468b97a9a806dd11343b,
title = "A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus",
abstract = "Experimental and epidemiological data suggest that factors of one-carbon metabolism are important in the pathogenesis of several cancers, but prospective data on head and neck cancer (HNC) and esophagus cancer are limited. The European Prospective Investigation into Cancer and Nutrition (EPIC) study recruited 385,747 participants from 10 countries who donated a blood sample. The current study included 516 cancer cases of the head and neck and esophagus and 516 individually matched controls. Plasma levels of vitamins B2, B6, B9 (folate), B12, and methionine and homocysteine were measured in pre-diagnostic plasma samples and analyzed in relation to HNC and esophagus cancer risk, as well as post-diagnosis all-cause mortality. After controlling for risk factors, study participants with higher levels of homocysteine had elevated risk of HNC, the odds ratio (OR) in conditional analysis when comparing the top and bottom quartiles of homocysteine [ORQ4 vs. Q1] being 2.13 (95{\%} confidence interval [95{\%} CI] 1.13-4.00, p for trend 0.009). A slight decrease in HNC risk was also seen among subjects with higher levels of folate (ORQ4 vs. Q1 0.63, 95{\%} CI 0.35-1.16, p for trend 0.02). Subgroup analyses by anatomical sub-site indicated particularly strong associations with circulating homocysteine for oral cavity and gum cancer (p for trend 8 × 10-4), as well as for oropharynx cancer (p for trend 0.008). Plasma concentrations of the other investigated biomarkers did not display any clear association with risk or survival. In conclusion, study participants with elevated circulating levels of homocysteine had increased risk of developing squamous cell carcinoma of the head and neck.",
keywords = "EPIC, Head and neck cancer, One-carbon metabolism",
author = "Anouar Fanidi and Caroline Relton and Ueland, {Per Magne} and {\O}ivind Midttun and Vollset, {Stein Emil} and Travis, {Ruth C.} and Antonia Trichopoulou and Pagona Lagiou and Dimitrios Trichopoulos and Bueno-De-Mesquita, {H. Bas} and Martine Ros and Heiner Boeing and Rosario Tumino and Salvatore Panico and Domenico Palli and Sabina Sieri and Paolo Vineis and S{\'a}nchez, {Mar{\'i}a Jos{\'e}} and Huerta, {Jos{\'e} Mar{\'i}a} and Gurrea, {Aurelio Barricarte} and Leila Luj{\'a}n-Barroso and Quir{\'o}s, {J. Ram{\'o}n} and Anne Tj{\o}nneland and Jytte Halkj{\ae}r and Boutron-Ruault, {Marie Christine} and Fran{\cc}oise Clavel-Chapelon and Claire Cadeau and Elisabete Weiderpass and Mikael Johansson and Elio Riboli and Paul Brennan and Mattias Johansson",
year = "2015",
month = "2",
day = "15",
doi = "10.1002/ijc.29051",
language = "English",
volume = "136",
pages = "915--927",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus

AU - Fanidi, Anouar

AU - Relton, Caroline

AU - Ueland, Per Magne

AU - Midttun, Øivind

AU - Vollset, Stein Emil

AU - Travis, Ruth C.

AU - Trichopoulou, Antonia

AU - Lagiou, Pagona

AU - Trichopoulos, Dimitrios

AU - Bueno-De-Mesquita, H. Bas

AU - Ros, Martine

AU - Boeing, Heiner

AU - Tumino, Rosario

AU - Panico, Salvatore

AU - Palli, Domenico

AU - Sieri, Sabina

AU - Vineis, Paolo

AU - Sánchez, María José

AU - Huerta, José María

AU - Gurrea, Aurelio Barricarte

AU - Luján-Barroso, Leila

AU - Quirós, J. Ramón

AU - Tjønneland, Anne

AU - Halkjær, Jytte

AU - Boutron-Ruault, Marie Christine

AU - Clavel-Chapelon, Françoise

AU - Cadeau, Claire

AU - Weiderpass, Elisabete

AU - Johansson, Mikael

AU - Riboli, Elio

AU - Brennan, Paul

AU - Johansson, Mattias

PY - 2015/2/15

Y1 - 2015/2/15

N2 - Experimental and epidemiological data suggest that factors of one-carbon metabolism are important in the pathogenesis of several cancers, but prospective data on head and neck cancer (HNC) and esophagus cancer are limited. The European Prospective Investigation into Cancer and Nutrition (EPIC) study recruited 385,747 participants from 10 countries who donated a blood sample. The current study included 516 cancer cases of the head and neck and esophagus and 516 individually matched controls. Plasma levels of vitamins B2, B6, B9 (folate), B12, and methionine and homocysteine were measured in pre-diagnostic plasma samples and analyzed in relation to HNC and esophagus cancer risk, as well as post-diagnosis all-cause mortality. After controlling for risk factors, study participants with higher levels of homocysteine had elevated risk of HNC, the odds ratio (OR) in conditional analysis when comparing the top and bottom quartiles of homocysteine [ORQ4 vs. Q1] being 2.13 (95% confidence interval [95% CI] 1.13-4.00, p for trend 0.009). A slight decrease in HNC risk was also seen among subjects with higher levels of folate (ORQ4 vs. Q1 0.63, 95% CI 0.35-1.16, p for trend 0.02). Subgroup analyses by anatomical sub-site indicated particularly strong associations with circulating homocysteine for oral cavity and gum cancer (p for trend 8 × 10-4), as well as for oropharynx cancer (p for trend 0.008). Plasma concentrations of the other investigated biomarkers did not display any clear association with risk or survival. In conclusion, study participants with elevated circulating levels of homocysteine had increased risk of developing squamous cell carcinoma of the head and neck.

AB - Experimental and epidemiological data suggest that factors of one-carbon metabolism are important in the pathogenesis of several cancers, but prospective data on head and neck cancer (HNC) and esophagus cancer are limited. The European Prospective Investigation into Cancer and Nutrition (EPIC) study recruited 385,747 participants from 10 countries who donated a blood sample. The current study included 516 cancer cases of the head and neck and esophagus and 516 individually matched controls. Plasma levels of vitamins B2, B6, B9 (folate), B12, and methionine and homocysteine were measured in pre-diagnostic plasma samples and analyzed in relation to HNC and esophagus cancer risk, as well as post-diagnosis all-cause mortality. After controlling for risk factors, study participants with higher levels of homocysteine had elevated risk of HNC, the odds ratio (OR) in conditional analysis when comparing the top and bottom quartiles of homocysteine [ORQ4 vs. Q1] being 2.13 (95% confidence interval [95% CI] 1.13-4.00, p for trend 0.009). A slight decrease in HNC risk was also seen among subjects with higher levels of folate (ORQ4 vs. Q1 0.63, 95% CI 0.35-1.16, p for trend 0.02). Subgroup analyses by anatomical sub-site indicated particularly strong associations with circulating homocysteine for oral cavity and gum cancer (p for trend 8 × 10-4), as well as for oropharynx cancer (p for trend 0.008). Plasma concentrations of the other investigated biomarkers did not display any clear association with risk or survival. In conclusion, study participants with elevated circulating levels of homocysteine had increased risk of developing squamous cell carcinoma of the head and neck.

KW - EPIC

KW - Head and neck cancer

KW - One-carbon metabolism

UR - http://www.scopus.com/inward/record.url?scp=84918795557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918795557&partnerID=8YFLogxK

U2 - 10.1002/ijc.29051

DO - 10.1002/ijc.29051

M3 - Article

C2 - 24975698

AN - SCOPUS:84918795557

VL - 136

SP - 915

EP - 927

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -